Definium Therapeutics, Inc. (DFTX) Technical Analysis & Indicators
Definium Therapeutics, Inc. (DFTX) — Price $35.68 (closing price, October 28, 2026) — Healthcare — Biotechnology — NASDAQ
Latest reported results:
Technical analysis of Definium Therapeutics, Inc. (DFTX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD).